Observational studyJournal of gastroenterology2019

Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections.

Hitomi Sezaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.